Johanna G. H. van Nes

Author

Also Known As

Cooperating Investigators of the EORTC, J G H van Nes, J. G. H. van Nes, J.G.H. Van Nes, J.G.H. van Nes, Janine G.H. van Nes, Johanna G H van Nes, Johanna G. H. van Nes, Johanna G.H. van Nes

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Leiden University Amsterdam UMC Location University of Amsterdam University Medical Center Groningen University of Groningen

About

Johanna G. H. van Nes is an author at Leiden University Medical Center specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	866
2	Nursing	3	3	116
3	Cell Biology	2	2	136
4	Health Sciences	1	1	67
5	Biostatistics	1	1	15

Johanna G. H. van Nes

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients Esther M. de Kruijf, Johanna G. H. van Nes, Cornelis J.�H. van de Velde, Breast Cancer Research and Treatment Triple-negative Carcinoma PatientsBreast OncologyMedicinePathologyTumor–stroma Ratio	2010	282
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients Esther M. de Kruijf, Anita Sajet, Johanna G. H. van Nes, The Journal of Immunology Breast OncologyBinary ScoreMedicinePrognostic ValueImmunology	2010	261
The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer Esther M. de Kruijf, Johanna G. H. van Nes, Anita Sajet, Clinical Cancer Research	2010	110
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients Johanna G. H. van Nes, Esther M. de Kruijf, Hein Putter, Breast Cancer Research and Treatment Breast OncologyMedicineHormonal ReceptorCancer Cell BiologyPathology	2011	84
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study Anneke Q. van Hoesel, Cornelis J.�H. van de Velde, Peter J.K. Kuppen, Breast Cancer Research and Treatment Retrospective Cohort StudyBreast OncologyMedicinePathologyBreast Cancer	2012	82
Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients Dorien W. Voskuil, Johanna G. H. van Nes, Jan M. C. Junggeburt, Annals of Oncology NursingQuality Of LifePhysical ActivityKinesiologyWeight Management	2010	67
Expression of cell adhesion molecules and prognosis in breast cancer S. Saadatmand, Esther M. de Kruijf, Anita Sajet, British journal of surgery	2012	63
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study Johanna G. H. van Nes, D.B.Y. Fontein, E.T.M. Hille, Breast Cancer Research and Treatment	2012	60
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients Johanna G. H. van Nes, Esther M. de Kruijf, Dana Faratian, Breast Cancer Research and Treatment Breast OncologyCox2 ExpressionMedicinePathologyBreast Cancer	2010	52
Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014 Paul M. Jeene, Kim C. de Vries, Johanna G. H. van Nes, Acta Oncologica	2017	38

Page 1